Reinventing Clinical Development and Overcoming Unnecessary Complexity

About this session

Session: TUESDAY MORNING PLENARY SESSION: REINVENTING CLINICAL DEVELOPMENT & CONVERGING RESEARCH WITH CLINICAL CARE

This keynote presentation proposes a paradigm shift in clinical development, advocating for the adoption of a minimal viable product (MVP) approach focused solely on fulfilling regulatory requirements. By streamlining processes and resources to the essentials, this strategy promises significant cost reductions and time efficiencies while maintaining regulatory compliance. Through case studies and implementation strategies, attendees will gain insights into how embracing this innovative approach can revolutionise clinical development, paving the way for greater agility, adaptability, and patient-centricity in the industry.

Speaker

• 

  Bernhard Glombitza

  Head Clinical Customer Engagement and Clinical Operations EMEA/LATAM · Bayer

  Speaker